Pigmentation & Skin Brightening Testing
Advanced Pigmentation & Skin Brightening Research for Cosmetics and Dermatology
ImmunitasBio offers advanced pigmentation testing services to evaluate the efficacy of skin brightening, depigmentation, and pigmentation-modulating ingredients. Our cell-based and ex vivo skin models provide mechanistic insights into melanin synthesis, tyrosinase activity, and melanosome transfer, generating robust scientific evidence for product development and claims substantiation.
Our Capabilities :
Melanogenesis Inhibition Assays
Evaluate melanin production and tyrosinase activity using B16F10 melanoma cells and primary human melanocytes to assess the depigmenting efficacy of cosmetic and dermatological formulations.
Melanosome Transfer Analysis
Assess the inhibition of melanosome transfer between melanocytes and keratinocytes using advanced co-culture models, providing physiologically relevant evidence for skin brightening and even skin tone claims.
Ex Vivo Skin Brightening Studies
Validate visible skin lightening and pigmentation reduction by applying test compounds to human skin explants, delivering highly translational efficacy data under real tissue conditions.
Why ImmunitasBio?
- Human melanocyte and ex vivo skin models
- Mechanism-based pigmentation and brightening studies
- Quantitative melanin and tyrosinase analysis
- High-quality, reproducible, publication-ready data
- Scientific support for cosmetic, cosmeceutical, and dermatology product claims
Accelerate the development of skin brightening innovations with scientifically validated pigmentation assays that deliver reliable, evidence-based efficacy data.
